Zoetis Inc

ZTSNYSE · USD
70.53USD-0.90 (-1.26%)
862

Zoetis Inc (ZTS) Covered Calls

As of September 28, 2026, ZTS has 92 covered call opportunities in the coming three months. Return ranges from 5.9 to 208.5% until expiration. Annualized return ranges from 11.2 to 386.6%. The nearest expiration is October 16, 2026. Maximum potential profit is $14,892.

Read more

Running ZTS covered calls helps you generate consistent income from Zoetis Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Zoetis Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ZTS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ZTS stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ZTS covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Zoetis Inc covered call is worth writing.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms.

It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Income-focused investors, long-term ZTS holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ZTS covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Zoetis Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile49.40% Neutral
  • Market cap (M$)29,517
  • 52 weeks high-51.99%
  • 52 weeks low2.75%
  • Analyst recommendationBuy
    2.26
  • Target price$90.58
    29.02% above the current stock price
  • Dividend—
  • Payout ratio33.71%
  • Earnings date2026-11-05
  • P/E11.75
  • Future P/E11.05
  • EPS (ttm)6.08
  • EPS growth next 5 years3.07%

As of September 28, 2026

2026-10-161885.0019.000.050.301362.0019.07386.65-0.07+0.061,8610.25
2026-12-1881120.0068.000.050.404862.0068.07306.72-0.07+0.032450.35
2026-10-161880.0012.000.150.35872.0012.21247.55-0.21+0.093,8290.20
2027-03-19172150.00110.000.050.407862.00110.07233.57-0.07+0.03660.35
2026-11-205395.0033.000.050.452362.0033.07227.73-0.07+0.05120.40
2027-03-19172145.00103.000.050.957362.00103.07218.72-0.07+0.0510.90
2026-11-205390.0026.000.400.551897.0026.56182.90-0.56+0.091070.15
2026-12-1881100.0040.000.200.602877.0040.28181.50-0.28+0.078040.40
2028-01-21480220.00207.990.351.5014892.00208.48158.53-0.49+0.061,5071.15
2027-01-15109105.0047.000.150.503372.0047.21158.08-0.21+0.053,6780.35

As of September 28, 2026

Sell covered calls with the data behind you

Find the best ZTS covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial